-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Top 5 Health Care Stocks That May Dip
Top 5 Health Care Stocks That May Dip
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70.
Here's the latest list of major overbought players in this sector.
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS)
- NewAmsterdam Pharma announced topline results from ROSE2 Phase 2 trial evaluating obicetrapib in combination with ezetimibe as an adjunct to high-intensity statin therapy. The company's stock has a 52-week high of $32.88 .
- RSI Value: 76.31
- NAMS Price Action: Shares of NewAmsterdam Pharma jumped 20% to settle at $13.56 on Thursday and added 4.9% in after-hours trading.
AN2 Therapeutics, Inc. (NASDAQ:ANTX)
- AN2 Therapeutics, during November, posted a Q3 loss of $0.59 per share. The company's stock has a 52-week high of $23.58.
- RSI Value: 76.53
- ANTX Price Action: Shares of AN2 Therapeutics jumped 17.5% to close at $12.31 on Thursday and added 5% in after-hours trading.
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN)
- CollPlant recently announced pre-clinical results in 3D bioprinted regenerative breast implants porcine study and full achievement of objectives. The company has a 52-week high of $14.77.
- RSI Value: 77.04
- CLGN Price Action: Shares of CollPlant Biotechnologies rose 12.9% to close at $11.21 on Thursday and added 5.4% in after-hours trading.
GlycoMimetics, Inc. (NASDAQ:GLYC)
- GlycoMimetics, last month, announced new uproleselan clinical data in both frontline unfit and treated secondary acute myeloid leukemia presented at ASH Annual Meeting. The company's 52-week high is $3.48.
- RSI Value: 71.64
- GLYC Price Action: Shares of GlycoMimetics rose 8.1% to close at $3.35 on Thursday and added 1.5% in after-hours trading.
Meihua International Medical Technologies Co., Ltd. (NASDAQ:MHUA)
- Meihua International Medical Technologies recently entered into strategic partnership with Getein Biotech Inc. to jointly produce and sell Covid-19 antigen test kits and IVDs. The company has a 52-week high of $14.94.
- RSI Value: 74.42
- MHUA Price Action: Shares of Meihua International Medical Technologies rose 9.7% to settle at $13.49 on Thursday and added 2.3% in after-hours trading.
Read More: Investor Optimism Improves Further Following GDP Report
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
醫療保健行業中最多的超買股票提供了對這些高估公司做空的機會。
The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70.
RSI 是一個動量指標,它比較股票在價格下跌的日子裡價格上升到其強勢的日子裡的實力。與股票的價格走勢相比,它可以使交易者更好地了解股票在短期內的表現。當 RSI 高於 70 時,資產通常被認為是超買。
Here's the latest list of major overbought players in this sector.
這是該領域主要超買參與者的最新列表。
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS)
新阿姆斯特丹製藥公司 N.V. (納斯達克:名稱)
- NewAmsterdam Pharma announced topline results from ROSE2 Phase 2 trial evaluating obicetrapib in combination with ezetimibe as an adjunct to high-intensity statin therapy. The company's stock has a 52-week high of $32.88 .
- RSI Value: 76.31
- NAMS Price Action: Shares of NewAmsterdam Pharma jumped 20% to settle at $13.56 on Thursday and added 4.9% in after-hours trading.
- 新阿姆斯特丹製藥公司宣布了 ROSE2 第二期試驗的頂線結果,結合使用巴西曲比作為高強度他汀類療法的輔助物質。該公司的股票有 五十二周新高點,達到 32 美元 。
- RSI 值: 76.31
- 名稱價格行動: 新阿姆斯特丹製藥公司股價上週四躍升 20%,收於 13.56 美元,收市後交易時段增加 4.9%。
AN2 Therapeutics, Inc. (NASDAQ:ANTX)
AN2 治療, 公司. (納斯達克:螞蟻)
- AN2 Therapeutics, during November, posted a Q3 loss of $0.59 per share. The company's stock has a 52-week high of $23.58.
- RSI Value: 76.53
- ANTX Price Action: Shares of AN2 Therapeutics jumped 17.5% to close at $12.31 on Thursday and added 5% in after-hours trading.
- AN2 治療學在 11 月期間發布了每股 0.59 美元的第三季度虧損。該公司的 股票有 52 周新高 的二百五十八美元。
- RSI 值: 76.53
- ANTX 的價格行動: AN2 治療藥物的股份在周四上漲 17.5%,收盤價為 12.31 美元,收市後交易時段增加 5%。
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN)
科立生物科技有限公司 (納斯達克:克隆)
- CollPlant recently announced pre-clinical results in 3D bioprinted regenerative breast implants porcine study and full achievement of objectives. The company has a 52-week high of $14.77.
- RSI Value: 77.04
- CLGN Price Action: Shares of CollPlant Biotechnologies rose 12.9% to close at $11.21 on Thursday and added 5.4% in after-hours trading.
- CollPlant 最近宣布了 3D 活檢再生乳房植入物豬研究的臨床前結果,並全面實現目標。該公司有一個 五十二周最高點 的 14.77 美元。
- RSI 值: 77.04
- CLGN 價格行動: 科林生物科技股份上漲 12.9%,上週四收盤 11.21 美元,收盤後交易時段增加 5.4%。
GlycoMimetics, Inc. (NASDAQ:GLYC)
糖氨酸學, 公司. (納斯達克:甘糖)
- GlycoMimetics, last month, announced new uproleselan clinical data in both frontline unfit and treated secondary acute myeloid leukemia presented at ASH Annual Meeting. The company's 52-week high is $3.48.
- RSI Value: 71.64
- GLYC Price Action: Shares of GlycoMimetics rose 8.1% to close at $3.35 on Thursday and added 1.5% in after-hours trading.
- 上個月公佈的糖合化學 新的連鎖臨床數據 在前線不適合和治療的繼發性急性髓細胞白血病在 ASH 年會上呈現。該公司的 52 周高點是 3.48 美元。
- RSI 值: 71.64
- GLYC 價格行動: 糖複合物的股份上漲 8.1%,週四收於 3.35 美元,收盤後交易時段增加 1.5%。
Meihua International Medical Technologies Co., Ltd. (NASDAQ:MHUA)
梅花國際醫療技術有限公司 (納斯達克:姆華)
- Meihua International Medical Technologies recently entered into strategic partnership with Getein Biotech Inc. to jointly produce and sell Covid-19 antigen test kits and IVDs. The company has a 52-week high of $14.94.
- RSI Value: 74.42
- MHUA Price Action: Shares of Meihua International Medical Technologies rose 9.7% to settle at $13.49 on Thursday and added 2.3% in after-hours trading.
- 梅花國際醫療科技最近與基坦生物科技股份有限公司達成戰略合作夥伴關係,共同生產和銷售 Covid-19 抗原檢 test 劑盒和 IVD。該公司 有 52 周的新高 的 14.94 美元。
- RSI 值: 74.42
- MHUA 價格行動: 梅花國際醫療科技股份於周四上漲 9.7%,收於 13.49 美元,收市後交易時段增加 2.3%。
Read More: Investor Optimism Improves Further Following GDP Report
閱讀更多: GDP 報告後投資者樂觀情緒進一步改善
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧